tickrz reports
CVS Health Corp (CVS)
Healthcare | Health Services
79.45  0.84%
CVS vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
CVSSECTORS&P 500
P/E RATIO15.9432.921.12
EV/EBITDA RATIO8.8718.312.66
P/S RATIO0.443.92.25
P/B RATIO2.35.83.45
QUALITY
RETURN ON EQUITY14.24%14.19%13.64%
RETURN ON CAPITAL9.74%20.57%10.09%
NET MARGIN2.98%8.82%9.73%
DIVIDEND ANALYSIS
DIVIDEND YIELD
2.54%
PAYOUT RATIO39.56%
3 YR DIVIDEND GROWTH23.17%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
6 OUT OF 9
DEBT-TO-EQUITY74%
INTEREST COVERAGE9.8x
CURRENT RATIO1.05
GROWTH
5 YR EPS GROWTH13.46%
5 YR SPS GROWTH10.64%
5 YR BPS GROWTH3.44%
About tickrz
Key Concepts
Great Investors
CVS Health Corp ranks well on valuation
TICKRZBOT SUMMARY
CVS Health Corp receives an A ranking in our multi-factor model that blends valuation, moat, operational performance, and financial strength. View the tickrz MFM Screener here. Here's a summary of CVS Health Corp's factor rankings that are combined together to calculate the tickrz MFM ranking:

FACTOR RANKINGSFACTOR SCREENER 
TICKRZ MFM RANK A / 23PURE VALUE RANKA / 30
DIVIDEND RANKB / 178MOAT RANKA / 64
FINANCIAL STRENGTH RANKB / 120GROWTH RANKB / 133
MOMENTUM RANKD / 430
GURU ANALYSIS
Buffett Rank A / 2Peter Lynch Rank A / 59
CVS Health Corp ranks 2 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, CVS Health Corp warrants further investigation.Our Peter Lynch mutli-factor model ranks stocks on their PEG ratio, Financial Strength, margin profile, and their P/Es relative to their respective industry groups. CVS Health Corp ranks 59, a relatively strong ranking. Of note is CVS Health Corp's PEG ratio of 1x places it in the top 25% of S&P 500 stocks.
Alex Roepers Rank A / 8Joel Greenblatt Rank A / 98
Alex Roepers, founder of Atlantic Investment Management, looks for stocks trading at low EV/EBITDA multiples with strong and consistent free cash flow. CVS Health Corp ranks 8 out of the S&P 500 constituents on our Roepers-inspired multi-factor model.In his best-selling The Little Book that Beats the Market, Greenblatt introduced the Magic Formula, a straightforward approach that ranks stocks on earnings yield and return on invested capital. CVS Health Corp places 98 out the S&P 500 consitituents on this ranking methodology.
FACTOR RANKINGS
Value
Pure Value Ranking A / 30
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. CVS Health Corp's valuation score is comprised of a P/E ratio of 15.9x, a P/B ratio of 2.3x, a P/S ratio of 0.4x, and an EV/EBITDA ratio of 8.9x. CVS Health Corp ranks 30 out of the S&P 500 constituents on valuation--a relatively strong score.

Quality
Moat A / 64Financial Strength B / 120
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is strong. CVS Health Corp appears to have a durable competitive advantage within the Healthcare sector. CVS Health Corp has a Piotroski F Score of 6 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 9.8x, a debt/equity ratio of 74% and a Moat Rank of 64 translate to an average Financial Strength score.


Momentum D / 430
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -11.8% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 430. Based on its 12 month stock performance, CVS Health Corp will not appeal to momentum investors.

Yield B / 178
Value + Yield
Shares currently yield 2.54%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, CVS Health Corp ranks 178 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

Growth B / 133
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 13.5% 5 year annualized EPS growth, 10.6% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 3.4% combine to produce this average score.

CVS Health Corp (CVS)
Healthcare | Health Services
79.45  0.84%


tickrz rank
A
VALUATION RATIOS
P/E Ratio15.94x
P/B Ratio2.3x
P/S Ratio0.44x
EV/EBITDA Ratio8.87x
DIVIDEND ANALYSIS
DIVIDEND YIELD
2.54%
PAYOUT RATIO39.56%
3 YR DIVIDEND GROWTH23.17%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
6 OUT OF 9
DEBT-TO-EQUITY74%
INTEREST COVERAGE9.8x
CURRENT RATIO1.05
MOAT
ROE14.24%
ROIC9.74%
Net Margin2.98%
GROWTH
5 YR EPS GROWTH13.46%
5 YR SPS GROWTH10.64%
5 YR BPS GROWTH3.44%

TICKRZ RANK
CVS Health Corp receives an A ranking in our multi-factor model that blends valuation, moat, operational performance, and financial strength. View the tickrz MFM Screener here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. CVS Health Corp's valuation score is comprised of a P/E ratio of 15.9x, a P/B ratio of 2.3x, a P/S ratio of 0.4x, and an EV/EBITDA ratio of 8.9x. CVS Health Corp ranks 30 out of the S&P 500 constituents on valuation--a relatively strong score.

WARREN BUFFETT RANKING
CVS Health Corp ranks 2 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, CVS Health Corp warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is strong. CVS Health Corp appears to have a durable competitive advantage within the Healthcare sector.

FINANCIAL STRENGTH
CVS Health Corp has a Piotroski F Score of 6 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 9.8x, a debt/equity ratio of 74% and a Moat Rank of 64 translate to an average Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -11.8% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 430. Based on its 12 month stock performance, CVS Health Corp will not appeal to momentum investors.

VALUE + YIELD
Shares currently yield 2.54%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, CVS Health Corp ranks 178 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 13.5% 5 year annualized EPS growth, 10.6% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 3.4% combine to produce this average score.